NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

酒糟:流行病學預測 ∼2027年

Rosacea - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 736693
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
酒糟:流行病學預測 ∼2027年 Rosacea - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的酒糟患病數在2016年估計為4,735萬9,758人。

本報告提供酒糟的相關調查,疾病概要,患者背景,主要7個國家性別、各類型、重症度的患病數及診斷數,診斷指南等總括性彙整。

目錄

第1章 重要洞察

第2章 酒糟:市場概要

  • 市場佔有率(成果值)
  • 市場佔有率(預測值)

第3章 疾病背景和概要

  • 簡介
  • 徵兆與症狀
  • 酒糟的分類
  • 病情和重病度
  • 病理生理學
  • 全基因組相關分析(GWAS)為基礎遺傳的背景
  • 原因和危險因素
  • 診斷

第4章 流行病學和患者人口

  • 主要的觀察

第5章 主要7個國家的酒糟患病數

第6章 主要7個國家的酒糟診斷數

第7章 酒糟的流行病學:各國

  • 美國
    • 前提和根據
    • 總患病數
    • 患病數:性別
    • 總診斷數
    • 診斷數:各類型
    • 診斷數:各重症度
  • 歐洲5個國家
    • 德國
      • 前提和根據
      • 總患病數
      • 患病數:性別
      • 總診斷數
      • 診斷數:各類型
      • 診斷數:各重症度
    • 法國
      • 前提和根據
      • 總患病數
      • 患病數:性別
      • 總診斷數
      • 診斷數:各類型
      • 診斷數:各重症度
    • 義大利
      • 前提和根據
      • 總患病數
      • 患病數:性別
      • 總診斷數
      • 診斷數:各類型
      • 診斷數:各重症度
    • 西班牙
      • 前提和根據
      • 總患病數
      • 患病數:性別
      • 總診斷數
      • 診斷數:各類型
      • 診斷數:各重症度
    • 英國
      • 前提和根據
      • 總患病數
      • 患病數:性別
      • 總診斷數
      • 診斷數:各類型
      • 診斷數:各重症度
  • 日本
    • 前提和根據
    • 總患病數
    • 患病數:性別
    • 總診斷數
    • 診斷數:各類型
    • 診斷數:各重症度

第8章 附錄

  • 調查方法

第9章 DelveInsight的服務內容

第10章 免責聲明

第11章 關於DelveInsight

目錄
Product Code: DIEI0203

DelveInsight's "Rosacea - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Rosacea epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Rosacea Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Rosacea in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Rosacea outlook. It also includes the explanation of changing trends of epidemiology outlining the Rosacea scenario.

Rosacea Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Rosacea thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Rosacea explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Rosacea Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Rosacea

Key assessments

  • Patient Segmentation in Rosacea
  • Rosacea Risk & Burden
  • Factors driving growth in a specific Rosacea patient population

Table of Contents

1. Report Introduction

2. Rosacea Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Rosacea in 2016
  • 2.2. Patient Share Distribution of Rosacea in 2028

3. Disease Background and Overview: Rosacea

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Rosacea in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Rosacea in 7MM - By Countries

5. Epidemiology of Rosacea by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Rosacea
    • 5.1.3. Sub-Type Specific cases of the Rosacea *
    • 5.1.4. Sex- Specific Cases of the Rosacea *
    • 5.1.5. Diagnosed Cases of the Rosacea
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Rosacea
    • 5.4.3. Sub-Type Specific cases of the Rosacea *
    • 5.4.4. Sex- Specific Cases of the Rosacea *
    • 5.4.5. Diagnosed Cases of the Rosacea
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Rosacea
    • 5.5.3. Sub-Type Specific cases of the Rosacea *
    • 5.5.4. Sex- Specific Cases of the Rosacea *
    • 5.5.5. Diagnosed Cases of the Rosacea
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Rosacea
    • 5.6.3. Sub-Type Specific cases of the Rosacea *
    • 5.6.4. Sex- Specific Cases of the Rosacea *
    • 5.6.5. Diagnosed Cases of the Rosacea
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Rosacea
    • 5.7.3. Sub-Type Specific cases of the Rosacea *
    • 5.7.4. Sex- Specific Cases of the Rosacea *
    • 5.7.5. Diagnosed Cases of the Rosacea
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Rosacea
    • 5.8.3. Sub-Type Specific cases of the Rosacea *
    • 5.8.4. Sex- Specific Cases of the Rosacea *
    • 5.8.5. Diagnosed Cases of the Rosacea
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Rosacea
    • 5.9.3. Sub-Type Specific cases of the Rosacea *
    • 5.9.4. Sex- Specific Cases of the Rosacea *
    • 5.9.5. Diagnosed Cases of the Rosacea

6. Unmet Needs of the Rosacea

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Rosacea in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Rosacea in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Rosacea in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Rosacea in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Rosacea in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Rosacea in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Rosacea in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Rosacea in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Rosacea in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Rosacea in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Rosacea in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Rosacea in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Rosacea in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Rosacea in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Rosacea in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Rosacea in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Rosacea in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Rosacea in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Rosacea in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Rosacea in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Rosacea in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Rosacea in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Rosacea in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Rosacea in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Rosacea in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Rosacea in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Rosacea in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Rosacea in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Rosacea in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Rosacea in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Rosacea in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Rosacea in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Rosacea in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Rosacea in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Rosacea in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Rosacea in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Rosacea in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Rosacea in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Rosacea in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Rosacea in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Rosacea in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Rosacea in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Rosacea in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Rosacea in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Rosacea in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Rosacea in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Rosacea in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Rosacea in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Rosacea in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Rosacea in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Rosacea in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Rosacea in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Rosacea in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Rosacea in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Rosacea in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Rosacea in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Rosacea in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Rosacea in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Rosacea in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Rosacea in Japan (2016-2028)